Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 10, Number 10—October 2004


Virus-specific RNA and Antibody from Convalescent-phase SARS Patients Discharged from Hospital

Hoe Nam Leong*†1Comments to Author , Kwai Peng Chan†1, Ali S Khan‡§, Lynette Oon†, Su Yun Se-Thoe†, Xin Lai Bai†, Daniel Yeo*, Yee Sin Leo*, Brenda Ang*, Thomas G. Ksiazek‡, and Ai Ee Ling†
Author affiliations: *Tan Tock Seng Hospital, Singapore; †Singapore General Hospital, Singapore; ‡Centers for Diseases Control and Prevention, Atlanta, Georgia, USA; §Global Outbreak Alert and Response Network, Geneva, Switzerland

Main Article


Clinical and laboratory parameters of patients with stool samples positive for SARS-CoV RNAa

Patient no. Age Sex Ethnicity Occupation Specimens provided Viral loadb (copies/mL) History of ICU admission Required supplemental oxygen Peak LDH U/L Concurrent illness
3 43 Male Malay Unemployed Wk 5c Wk 5 ( 33.9 x 103) No No 299 Diabetes mellitus type 2
Steroid use
16 33 Female Indian Domestic maid Wks 4,c 5,6 Wk 4 (37.1 x 103) No Yes, I/N 1,127 None
35 17 Male Chinese Student Wk 9c Wk 9 (1.73 x 103) No No 615 None
51 30 Female Filipino Healthcare worker Wks 5,c 6c Wk 5 (2 x 103)
Wk 6 (1.64 x 103) No No 1,065 None
62 35 Male Chinese Diver Wk 5c Wk 5 (7.76 x 103) No Yes, I/N 952 None

aSARS-CoV, severe acute respiratory syndrome–associated coronavirus; ICU, intensive care unit; LDH, lactate dehydrogenase; I/N, intranasal oxygen.
bRT-PCR was performed by using the RealArt HPA-coronavirus RT-PCR kit (Artus Gmbh, Hamburg, Germany) on the Roche Lightcycler. Viral load was determined for each mL of stool sample.
cPositive RT-PCR results for SARS-CoV.

Main Article

1These authors contributed equally to this paper.

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO